Antibiotic Therapy and Bacterial Resistance in Patients With Spinal Cord Injury

By Young R. Lee, PharmD, BCPS; Carrie A. Tashjian, PharmD, BCPS; Sara D. Brouse, PharmD, BCPS; Roger J. Bedimo, MD; Lance L. Goetz, MD; Daisha J. Cipher, PhD; and Susan M. Duquaine, PharmD, BCPS (AQ-ID)

Dr. Lee is an assistant professor of pharmacy practice at the Texas Tech University Health Sciences Center School of Pharmacy in Abilene, Texas. Dr. Tashjian is a clinical pharmacy specialist in emergency medicine at Bon Secours St. Mary’s Hospital and a clinical assistant professor with Virginia Commonwealth University, both in Richmond, Virginia. Dr. Brouse is the cardiology clinical coordinator at UK HealthCare and an adjunct associate professor at the University of Kentucky College of Pharmacy, both in Lexington, Kentucky. Dr. Bedimo is chief of the Infectious Diseases section at the VA North Texas Health Care System and an associate professor of medicine at University of Texas Southwestern Medical Center, both in Dallas, Texas. Dr. Goetz is a staff physician in the Spinal Cord Injury and Disorders section at Hunter Holmes McGuire VAMC and an associate professor with the Department of Physical Medicine and Rehabilitation at Virginia Commonwealth University, both in Richmond, Virginia. Dr. Cipher is a biostatistical consultant for the Dallas VA Research Corporation in Dallas, Texas, and assistant to the dean for biostatistics at the University of Texas at Arlington College of Nursing in Arlington, Texas. Dr. Duquaine is a clinical pharmacy specialist in infectious disease at the VA North Texas Health Care System and an adjunct clinical assistant professor at Texas Tech University Health Sciences Center School of Pharmacy, in Dallas, Texas.